scholarly journals Infrequent p53 Gene Mutations and Lack of p53 Protein Expression in Clear Cell Sarcoma of the Kidney: Immunohistochemical Study and Mutation Analysis of p53 in Renal Tumors of Unfavorable Prognosis

2002 ◽  
Vol 15 (6) ◽  
pp. 606-610 ◽  
Author(s):  
Chuen Hsueh ◽  
Hao Wang ◽  
Frank Gonzalez-Crussi ◽  
Jer-Nan Lin ◽  
Iou-Jih Hung ◽  
...  
1999 ◽  
Vol 435 (4) ◽  
pp. 407-412 ◽  
Author(s):  
R. Schneider-Stock ◽  
D. Onnasch ◽  
C. Haeckel ◽  
W. Mellin ◽  
D.-S. Franke ◽  
...  

2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S59-S60
Author(s):  
Krutika Patel ◽  
Sara Avalos Hernandez ◽  
S Shawn Liu ◽  
J Elliot Carter ◽  
Elizabeth Manci

Abstract Introduction Clear cell sarcoma of kidney (CCSK) is a rare malignancy accounting for <0.5% of all primary renal tumors, commonly diagnosed between 2 and 4 years of age and rarely occurring in early infancy. The challenging differentiation between CCSK and blastemal Wilms tumor is important because of the distinct clinical pattern of CCSK to recur and metastasize to bone and brain. The aim of this study is to discern subtle features that could assist pathologists in diagnosing CCSK in infancy. Method In-depth comparison of clinical, histological, and immunohistochemical findings in a case of CCSK diagnosed at 5 months of age with two cases of CCSK diagnosed at 2 and 3 years of age. Results Both groups were male, and each presented with an abdominal mass. Grossly, a single, firm, well-demarcated tumor, morphologically comprising monotonous small primitive round-to-polygonal/spindle cells, was seen in both groups. The major differences between the study groups were growth patterns and stromal reactions. In infancy, the growth pattern was diffusely uniform sheets of malignant cells with no entrapment of tubules and inconspicuous stromal changes. However, in childhood cases, the growth pattern included well-defined tubular entrapment, as well as focal microcyst formation, myxomatous stroma, palisading bodies, and anaplastic and/or rhabdoid histology. In both study groups, the immunohistochemistry showed strong immunoreactivity with cyclin D1 and nonspecific positivity for vimentin, CD99, and BAF47. Conclusion CCSK has notoriously diverse histological heterogeneity and mimics other pediatric renal tumors, making diagnosis treacherous, and commonly erroneous as Wilms tumor with unfavorable histology. Despite the advent of immunohistochemical and molecular techniques, a thorough morphologic analysis remains key in accurately diagnosing CCSK at any age, especially in early infancy. This small in-depth comparison of CCSK by age groups suggests that tubular entrapment and stromal changes may be less conspicuous in CCSK in early infancy than at older ages.


1996 ◽  
Vol 60 (3) ◽  
pp. 339-344 ◽  
Author(s):  
Steven E. Waggoner ◽  
Steven M. Anderson ◽  
Michael C. Luce ◽  
Hiroyuki Takahashi ◽  
Jeff Boyd

1986 ◽  
Vol 36 (5) ◽  
pp. 681-689
Author(s):  
Katsuhiko Ogawa ◽  
Yasuaki Nakashima ◽  
Hirohiko Yamabe ◽  
Yoshihiro Hamashima

2003 ◽  
Vol 2 (3) ◽  
pp. 223-235 ◽  
Author(s):  
Tatyana M. Timiryasova ◽  
Daila S. Gridley ◽  
Bing Chen ◽  
Melba L. Andres ◽  
Radha Dutta-Roy ◽  
...  

The overall goal of this study was to analyze the effect and mechanism of radiation in combination with vaccinia viruses (VV) carrying the p53 gene against glioma. Comparison of two alternative treatments of cultured C6 (p53+) and 9L (p53−) rat glioma cells showed significantly reduced survival for both cell lines, especially 9L, when radiation was applied prior to virus versus radiation alone. High p53 protein expression mediated by VV-TK-p53 was measured in infected cells. Single modality treatment of C6 cells with psoralen and UV (PUV)-inactivated VV-TK-p53 (PUV-VV-TK-53) or radiation significantly decreased survival compared with PUV-inactivated L-15 (PUV-L-15) control virus. However, no difference was observed between radiation and combination treatments of C6 cells. In contrast, radiation followed by PUV-VV-TK-53 resulted in dramatic reduction of 9L cell viability, compared to single modality treatment. Flow cytometry analysis of Annexin-V-stained 9L cells showed that radiation and PUV-VV-TK-53 caused a significant decrease in live cells (17.2%) as compared to other treatments and control (61.6–98.3%). Apoptosis was observed in 37.2% of cells, while the range was 0.7–7.8% in other treatment groups; maximal p53 level was measured on day 7 post-infection. In athymic mice bearing C6 tumors, VV-TK-53 plus radiation in both single and multiple therapies resulted in significantly smaller tumors by day 30 compared to the agents given only once. Immunohistochemical analysis of tumor sections demonstrated p53 protein expression over 20 days after VV-TK-53 treatment. Analysis of blood and spleen cells of mice given multiple combination treatments showed significant splenomegaly, leukocytosis, and increased DNA synthesis and response to mitogen. Multiple combination treatments were also associated with significantly elevated natural killer and B cells in the spleen. There were no overt toxicities, although depression in red blood cell and thrombocyte parameters was noted. Collectively, the data demonstrate that radiation significantly improves the efficacy of VV-mediated tumor suppressor p53 therapy and may be a promising strategy for glioma treatment. Furthermore, the results support the conclusion that the mechanisms underlying the enhanced anti-tumor effect of combination treatment include apoptosis/necrosis and upregulation of innate immune defenses.


1993 ◽  
Vol 24 (9) ◽  
pp. 1026-1030 ◽  
Author(s):  
Yoshiko Kataoka ◽  
Hiroyuki Shimada ◽  
Tohru Sugimoto ◽  
Hiroshi Mine ◽  
Yoichi Hachitanda ◽  
...  

2019 ◽  
Vol 144 (1) ◽  
pp. 119-123 ◽  
Author(s):  
Alessandro Pietro Aldera ◽  
Komala Pillay

Clear cell sarcoma of the kidney is an uncommon malignant pediatric renal neoplasm that typically presents in the 2- to 3-year age group and has a propensity for aggressive behavior and late relapses. Histologically, this tumor exhibits a great diversity of morphologic patterns that can mimic most other pediatric renal neoplasms, often leading to confusion and misdiagnosis. Until recently, adjunct immunohistochemical and molecular genetic tests to support the diagnosis were lacking. The presence of internal tandem duplications in BCL-6 coreceptor (BCOR) and a translocation t(10;17) creating the fusion gene YWHAE-NUTM2B/E have now been well accepted. Immunohistochemistry for BCOR has also been shown to be a sensitive and specific marker for clear cell sarcoma of the kidney in the context of pediatric renal tumors. Improved intensive chemotherapy regimens have influenced the clinical course of the disease, with late relapses now being less frequent and the brain having overtaken bone as the most common site of relapse.


Sign in / Sign up

Export Citation Format

Share Document